• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4:CD8 T-cell ratio in treated HIV-1 infection.干扰素 lambda rs368234815ΔG/ΔG 与治疗后 HIV-1 感染中更高的 CD4:CD8 T 细胞比值相关。
AIDS Res Ther. 2020 Apr 15;17(1):13. doi: 10.1186/s12981-020-00269-0.
2
Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.与CD4+/CD8+ T细胞比值正常化相关的临床、免疫学及治疗相关因素:初始和记忆性T细胞亚群的作用
PLoS One. 2014 May 9;9(5):e97011. doi: 10.1371/journal.pone.0097011. eCollection 2014.
3
Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.干扰素 lambda 4 基因多态性 rs368234815 与血液透析患者丙型肝炎病毒自发清除的关系:一项病例对照研究。
BMC Infect Dis. 2021 Jan 22;21(1):102. doi: 10.1186/s12879-021-05777-6.
4
Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.在埃塞俄比亚长期抗逆转录病毒治疗下病毒持续抑制的 HIV-1 感染患者中的免疫恢复。
PLoS One. 2020 Oct 22;15(10):e0240880. doi: 10.1371/journal.pone.0240880. eCollection 2020.
5
Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.尽管接受了早期抗逆转录病毒治疗,潜伏性巨细胞病毒 DNA 与 HIV 感染者 CD4 T 细胞活化和 CD8 T 细胞 CD107a 表达受损有关。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00179-19. Print 2019 Jul 1.
6
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.在接受抗逆转录病毒治疗实现病毒载量抑制的 HIV 感染者中,CD4/CD8 比值正常化与非艾滋病相关事件:一项观察性队列研究。
Lancet HIV. 2015 Mar;2(3):e98-106. doi: 10.1016/S2352-3018(15)00006-5. Epub 2015 Feb 6.
7
Lower immune senescence of T cell subsets among virologically suppressed Chinese men who have sex with men living with HIV in comparison with those ART naive.与未接受抗逆转录病毒治疗的男性相比,病毒学抑制的中国男男性行为艾滋病毒感染者中T细胞亚群的免疫衰老程度较低。
BMC Infect Dis. 2025 Feb 28;25(1):290. doi: 10.1186/s12879-025-10511-7.
8
Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.1型人类免疫缺陷病毒(HIV-1)感染患者既往有蛋白酶抑制剂治疗史,接受高效抗逆转录病毒治疗后CD4+和CD8+ T细胞亚群的变化
AIDS Res Hum Retroviruses. 1998 May 1;14(7):561-9. doi: 10.1089/aid.1998.14.561.
9
Baseline Characteristics of Mitochondrial DNA and Mutations Associated With Short-Term Posttreatment CD4+T-Cell Recovery in Chinese People With HIV.中国人 HIV 患者短期治疗后 CD4+T 细胞恢复与线粒体 DNA 及突变的基线特征。
Front Immunol. 2021 Dec 14;12:793375. doi: 10.3389/fimmu.2021.793375. eCollection 2021.
10
Low CD4 count was characterized in recent HIV CRF01_AE infection and it rapidly increased to reach a peak in the first year since ART initiation.低CD4细胞计数是近期HIV CRF01_AE感染的特征,并且在开始抗逆转录病毒治疗后的第一年迅速上升至峰值。
BMC Infect Dis. 2025 Mar 31;25(1):443. doi: 10.1186/s12879-025-10799-5.

引用本文的文献

1
Associations between type III interferons, obesity and clinical severity of COVID-19.III型干扰素、肥胖与新型冠状病毒肺炎临床严重程度之间的关联。
Front Immunol. 2025 Apr 22;16:1516756. doi: 10.3389/fimmu.2025.1516756. eCollection 2025.
2
Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa.基因型与东非儿童伯基特淋巴瘤风险
J Interferon Cytokine Res. 2023 Sep;43(9):394-402. doi: 10.1089/jir.2023.0014. Epub 2023 Jun 27.
3
genotype influences the rate of HIV-1 seroconversion in men who have sex with men.基因型影响男男性行为者中 HIV-1 血清转换率。
Virulence. 2022 Dec;13(1):757-763. doi: 10.1080/21505594.2022.2066612.
4
HIV-1 Accessory Proteins Impart a Modest Interferon Response and Upregulate Cell Cycle-Related Genes in Macrophages.HIV-1辅助蛋白在巨噬细胞中引发适度的干扰素反应并上调细胞周期相关基因。
Pathogens. 2022 Jan 26;11(2):163. doi: 10.3390/pathogens11020163.

本文引用的文献

1
Interferon-λ orchestrates innate and adaptive mucosal immune responses.干扰素-λ 调控先天和适应性黏膜免疫应答。
Nat Rev Immunol. 2019 Oct;19(10):614-625. doi: 10.1038/s41577-019-0182-z. Epub 2019 Jun 14.
2
Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.干扰素-λ 通过促进胸腺基质淋巴细胞生成素的释放增强适应性黏膜免疫。
Nat Immunol. 2019 May;20(5):593-601. doi: 10.1038/s41590-019-0345-x. Epub 2019 Mar 18.
3
Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals.马拉维若与依非韦伦联合齐多夫定/拉米夫定治疗对初治 HIV 感染者 CD4/CD8 比值的影响。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01763-17. Print 2017 Dec.
4
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.HLA-B*57 和 IFNL4 相关多态性与控制者中 HIV-1 疾病进展的保护有关。
Clin Infect Dis. 2017 Mar 1;64(5):621-628. doi: 10.1093/cid/ciw833. Epub 2016 Dec 16.
5
Baseline CD4/CD8 T-Cell Ratio Predicts Prompt Immune Restoration Upon cART Initiation.基线CD4/CD8 T细胞比值可预测开始接受抗逆转录病毒治疗后迅速的免疫恢复。
Curr HIV Res. 2016;14(6):491-496. doi: 10.2174/1570162x14666160414111554.
6
Status of vaccine research and development of vaccines for HIV-1.人类免疫缺陷病毒1型(HIV-1)疫苗的研发现状
Vaccine. 2016 Jun 3;34(26):2921-2925. doi: 10.1016/j.vaccine.2016.02.074. Epub 2016 Mar 15.
7
CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染成人的CD4+/CD8+比值、年龄与严重非传染性疾病风险
AIDS. 2016 Mar 27;30(6):899-908. doi: 10.1097/QAD.0000000000001005.
8
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.尽管长期病毒抑制,HIV-1 感染者 CD4/CD8 比值低的决定因素。
Clin Infect Dis. 2016 May 15;62(10):1297-1303. doi: 10.1093/cid/ciw076. Epub 2016 Feb 14.
9
HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients.HIV-1包膜糖蛋白表型与免疫激活共同决定HIV患者CD4 T细胞的损失。
J Immunol. 2016 Feb 15;196(4):1768-79. doi: 10.4049/jimmunol.1501588. Epub 2016 Jan 13.
10
Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.抗逆转录病毒疗法与HIV感染患者治疗第一年CD4/CD8比值的正常化:一项队列研究
PLoS One. 2015 Oct 20;10(10):e0140519. doi: 10.1371/journal.pone.0140519. eCollection 2015.

干扰素 lambda rs368234815ΔG/ΔG 与治疗后 HIV-1 感染中更高的 CD4:CD8 T 细胞比值相关。

Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4:CD8 T-cell ratio in treated HIV-1 infection.

机构信息

Centre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin 4, Ireland.

Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, N20, W10, Kita-ku, Sapporo, 001-0020, Japan.

出版信息

AIDS Res Ther. 2020 Apr 15;17(1):13. doi: 10.1186/s12981-020-00269-0.

DOI:10.1186/s12981-020-00269-0
PMID:32295609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194102/
Abstract

BACKGROUND

The objectives of this study were to investigate the relationships between polymorphisms at the interferon lambda (IFNL) locus and CD4:CD8 ratio normalisation in people living with HIV (PLWH) on effective antiretroviral therapy (ART); and to examine whether these polymorphisms influence the composition of T lymphocyte compartments in long-term treated HIV-1 infection.

METHODS

A cross-sectional study in PLWH enrolled into the Mater Immunology study. We performed IFNL genotyping on stored samples and evaluated the association of IFNL single-nucleotide polymorphisms (rs368234815 and rs12979860) with CD4:CD8 ratio normalization (> 1) and expanded CD4 and CD8 T-cell subsets; CD45ROCD62L (central-memory), CD45RO CD62L(effector-memory) and CD45ROCD62L (naïve), using logistic and linear regression models, respectively.

RESULTS

190 ambulatory PLWH recruited to the main study, 143 were included in the analysis (38 had no stored DNA and 9 no T-lymphocyte subpopulation). Of 143 included, the median age (IQR) was 45(39-48) years, 64% were male and 66% were of Caucasian ethnicity. Heterosexual-contact (36%), injecting drug-use (33%) and men who have sex with men (24%) were the most presented HIV-transmission risk groups. The majority of subjects (90.2%) were on ART with 79% of the cohort having an undetectable HIV-RNA (< 40 copies/ml) and the time since ART initiation was 7.5 (3.7-10.4) year. rs368234815 and rs12979860 displayed similar allelic frequencies, with minor alleles ΔG and T representing 39% and 42%, respectively, of circulating alleles. rs368234815 ΔG/ΔG minor homozygotes were significantly associated with increased odds for attaining a normalised CD4:CD8 ratio compared to rs368234815 T/T major homozygotes in PLWH virologically suppressed on effective ART (OR = 3.11; 95% CI [1.01:9.56]). rs368234815 ΔG/ΔG homozygosity was also significantly associated with lower levels of CD4 effector memory T-cells (regression coefficient: - 7.1%, p = 0.04) and CD8 naïve T-cell subsets were significantly higher in HIV-1 mono-infected PLWH with rs368234815 ΔG/ΔG (regression coefficient: + 7.2%, p = 0.04).

CONCLUSIONS

In virally-suppressed, long-term ART-treated PLWH, rs368234815 ΔG/ΔG homozygotes were more likely to have attained normalisation of their CD4:CD8 ratio, displayed lower CD4 effector memory and higher naive CD8 T-cells. Further studies are needed to replicate our findings in other, larger and more diverse cohorts and to determine the impact of IFNL genetic-variation on CD4:CD8 ratio normalisation and clinical outcomes in PLWH.

摘要

背景

本研究旨在探讨干扰素 lambda (IFNL) 基因座多态性与接受有效抗逆转录病毒治疗 (ART) 的 HIV 感染者 (PLWH) 中 CD4:CD8 比值正常化之间的关系;并研究这些多态性是否会影响长期 HIV-1 感染中 T 淋巴细胞亚群的组成。

方法

本研究为 Mater Immunology 研究中的一项横断面研究。我们对存储样本进行 IFNL 基因分型,并使用逻辑回归和线性回归模型评估 IFNL 单核苷酸多态性 (rs368234815 和 rs12979860) 与 CD4:CD8 比值正常化 (>1) 和扩展的 CD4 和 CD8 T 细胞亚群的相关性;CD45ROCD62L(中央记忆)、CD45RO CD62L(效应记忆)和 CD45ROCD62L(幼稚)。

结果

190 名在主要研究中接受门诊治疗的 PLWH 中,有 143 名被纳入分析(38 名无存储 DNA,9 名无 T 淋巴细胞亚群)。在纳入的 143 名患者中,中位年龄(IQR)为 45(39-48) 岁,64%为男性,66%为白种人。异性接触(36%)、注射吸毒(33%)和男男性接触(24%)是最常见的 HIV 传播风险群体。大多数患者(90.2%)正在接受 ART 治疗,79%的患者 HIV-RNA 无法检测到(<40 拷贝/ml),ART 开始时间为 7.5(3.7-10.4)年。rs368234815 和 rs12979860 显示出相似的等位基因频率,其中 minor 等位基因 ΔG 和 T 分别代表循环等位基因的 39%和 42%。与 rs368234815 T/T 主要纯合子相比,rs368234815 ΔG/ΔG 小型纯合子在病毒学抑制的有效 ART 治疗的 PLWH 中获得正常 CD4:CD8 比值的可能性显著更高(OR=3.11;95%CI [1.01:9.56])。rs368234815 ΔG/ΔG 同型合子也与较低水平的 CD4 效应记忆 T 细胞显著相关(回归系数:-7.1%,p=0.04),而在 rs368234815 ΔG/ΔG 的 HIV-1 单感染 PLWH 中,CD8 幼稚 T 细胞亚群显著更高(回归系数:+7.2%,p=0.04)。

结论

在病毒抑制、长期接受 ART 治疗的 PLWH 中,rs368234815 ΔG/ΔG 同型合子更有可能实现 CD4:CD8 比值的正常化,表现为较低的 CD4 效应记忆和较高的幼稚 CD8 T 细胞。需要进一步的研究来在其他更大、更多样化的队列中复制我们的发现,并确定 IFNL 遗传变异对 PLWH 中 CD4:CD8 比值正常化和临床结果的影响。